跳至主要内容
临床试验/NCT05100043
NCT05100043已完成不适用

IL-4 and IFN-γ As Immunologic Predictors of Response to HPV Immunotherapy in Warts

Zagazig University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年1月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Change of IFN-γ and IL-4 levels

研究概览

简要总结

In the present study the investigators assessed the invitro role of IL-4 and IFN-γ in predicting the response to bivalent HPV vaccine after whole blood stimulation

详细描述

40 Patients and 40 controls are enrolled in the study. Participants suffer from chronic recurrent cutaneous and genital warts. Blood samples were withdrawn then whole blood cultures are prepared. Cultures are stimulated with bivalent HPVvaccine. IL-4 and IFN-γ measurement in culture supernatants by ELISA. IL-4 and IFN-γ are investigated to predict the therapeutic response to bivalent HPV vaccine immunotherapy in warts.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
36 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with recurrent and recalcitrant cutaneous and anogenital warts.

排除标准

  • History of allergy to the HPV vaccine
  • Active viral, fungal, or bacterial infections
  • Immunosuppressive diseases or drugs.
  • Autoimmune diseases, or other systemic diseases, e.g., hepatic, or renal disorders, diabetes, meningitis or convulsions
  • Skin allergies
  • Pregnancy and lactation
  • Earlier wart treatment at least one month before enrollment.

研究组 & 干预措施

Cases

Patients having multiple recurrent and recalcitrant cutaneous and genital warts

干预措施: IL-4 and IFN-γ measurements (Biological)

Controls

Healthy volunteers matched for age and sex

干预措施: IL-4 and IFN-γ measurements (Biological)

结局指标

主要结局

Change of IFN-γ and IL-4 levels

时间窗: 48 hours

Quantitative measurement of IFN-γ and IL-4 in culture supernatants

次要结局

  • Change in the size of warts(6 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Noha M Hammad, MD

Principal investigator

Zagazig University

研究点 (1)

Loading locations...

相似试验